Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2003 1
2006 2
2007 2
2010 2
2011 3
2012 1
2013 3
2014 5
2015 3
2016 3
2017 2
2018 10
2019 14
2020 20
2021 31
2022 13
Text availability
Article attribute
Article type
Publication date

Search Results

99 results
Results by year
Filters applied: . Clear all
Page 1
Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders.
Baswan SM, Klosner AE, Glynn K, Rajgopal A, Malik K, Yim S, Stern N. Baswan SM, et al. Clin Cosmet Investig Dermatol. 2020 Dec 8;13:927-942. doi: 10.2147/CCID.S286411. eCollection 2020. Clin Cosmet Investig Dermatol. 2020. PMID: 33335413 Free PMC article. Review.
In particular, cannabidiol (CBD), a non-psychoactive compound from the cannabis plant, has garnered significant attention in recent years for its anecdotal therapeutic potential for various pathologies, including skin and cosmetic disorders. Though a body of preclin …
In particular, cannabidiol (CBD), a non-psychoactive compound from the cannabis plant, has garnered significant attention in recent y …
The potential role of cannabinoids in dermatology.
Sheriff T, Lin MJ, Dubin D, Khorasani H. Sheriff T, et al. J Dermatolog Treat. 2020 Dec;31(8):839-845. doi: 10.1080/09546634.2019.1675854. Epub 2019 Oct 10. J Dermatolog Treat. 2020. PMID: 31599175 Review.
Cannabis is increasingly being used world-wide to treat a variety of dermatological conditions. Medicinal cannabis is currently legalized in Canada, 31 states in America and 19 countries in Europe. The authors reviewed the literature on the pharmacology and use of cannabin …
Cannabis is increasingly being used world-wide to treat a variety of dermatological conditions. Medicinal cannabis is currently legal …
Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury.
Sangiovanni E, Fumagalli M, Pacchetti B, Piazza S, Magnavacca A, Khalilpour S, Melzi G, Martinelli G, Dell'Agli M. Sangiovanni E, et al. Phytother Res. 2019 Aug;33(8):2083-2093. doi: 10.1002/ptr.6400. Epub 2019 Jun 27. Phytother Res. 2019. PMID: 31250491 Free article.
Skin inflammatory diseases result from complex events that include dysregulation and abnormal expression of inflammatory mediators or their receptors in skin cells. ...Our findings provide new insights into the potential effect of Cannabis extracts against in
Skin inflammatory diseases result from complex events that include dysregulation and abnormal expression of inflammatory media
A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars.
Palmieri B, Laurino C, Vadalà M. Palmieri B, et al. Clin Ter. 2019 Mar-Apr;170(2):e93-e99. doi: 10.7417/CT.2019.2116. Clin Ter. 2019. PMID: 30993303 Free article.
OBJECTIVE: To investigate the therapeutic effect of CBD-ointment administered on severe skin chronic diseases and/or on their outcome scars. METHODS: A spontaneous, anecdotal, retrospective study of 20 patients with two most frequent skin disorders: psoriasis …
OBJECTIVE: To investigate the therapeutic effect of CBD-ointment administered on severe skin chronic diseases and/or on their …
Cannabinoids for skin diseases and hair regrowth.
Gupta AK, Talukder M. Gupta AK, et al. J Cosmet Dermatol. 2021 Sep;20(9):2703-2711. doi: 10.1111/jocd.14352. Epub 2021 Aug 7. J Cosmet Dermatol. 2021. PMID: 34363728 Review.
The use of cannabis for skin diseases and hair regrowth is at the preliminary stage. LEGALIZATION: Many countries have approved cannabis for medical use; however, four countries Canada, Uruguay, South Africa, and Georgia have legalized it for both medical and recrea …
The use of cannabis for skin diseases and hair regrowth is at the preliminary stage. LEGALIZATION: Many countries have approve …
The antimicrobial potential of cannabidiol.
Blaskovich MAT, Kavanagh AM, Elliott AG, Zhang B, Ramu S, Amado M, Lowe GJ, Hinton AO, Pham DMT, Zuegg J, Beare N, Quach D, Sharp MD, Pogliano J, Rogers AP, Lyras D, Tan L, West NP, Crawford DW, Peterson ML, Callahan M, Thurn M. Blaskovich MAT, et al. Commun Biol. 2021 Jan 19;4(1):7. doi: 10.1038/s42003-020-01530-y. Commun Biol. 2021. PMID: 33469147 Free PMC article.
Multiple mode-of-action studies point to membrane disruption as cannabidiol's primary mechanism. More importantly, we now report for the first time that cannabidiol can selectively kill a subset of Gram-negative bacteria that includes the 'urgent threat' pathogen Ne …
Multiple mode-of-action studies point to membrane disruption as cannabidiol's primary mechanism. More importantly, we now report for …
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.
Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi AE, Martín-Santos R, Hallak JE, Zuardi AW, Crippa JA. Bergamaschi MM, et al. Neuropsychopharmacology. 2011 May;36(6):1219-26. doi: 10.1038/npp.2011.6. Epub 2011 Feb 9. Neuropsychopharmacology. 2011. PMID: 21307846 Free PMC article. Clinical Trial.
Generalized Social Anxiety Disorder (SAD) is one of the most common anxiety conditions with impairment in social life. Cannabidiol (CBD), one major non-psychotomimetic compound of the cannabis sativa plant, has shown anxiolytic effects both in humans and in animals. …
Generalized Social Anxiety Disorder (SAD) is one of the most common anxiety conditions with impairment in social life. Cannabidiol
Future Aspects for Cannabinoids in Breast Cancer Therapy.
Kisková T, Mungenast F, Suváková M, Jäger W, Thalhammer T. Kisková T, et al. Int J Mol Sci. 2019 Apr 3;20(7):1673. doi: 10.3390/ijms20071673. Int J Mol Sci. 2019. PMID: 30987191 Free PMC article. Review.
Indeed, the psychoactive delta-9-tetrahydrocannabinol (THC), non-psychoactive cannabidiol (CBD) and other CBs inhibited disease progression in breast cancer models. ...
Indeed, the psychoactive delta-9-tetrahydrocannabinol (THC), non-psychoactive cannabidiol (CBD) and other CBs inhibited disease progr …
A molecular basis for the anti-inflammatory and anti-fibrosis properties of cannabidiol.
Sunda F, Arowolo A. Sunda F, et al. FASEB J. 2020 Nov;34(11):14083-14092. doi: 10.1096/fj.202000975R. Epub 2020 Sep 3. FASEB J. 2020. PMID: 32885502 Review.
Cannabidiol (CBD) is considered a non-psychoactive, antioxidant, and anti-inflammatory compound derived from the Cannabis sativa plant. ...This review thus recommends the continued study of CBD's molecular mechanism in treating established and emerging inflammatory and fib
Cannabidiol (CBD) is considered a non-psychoactive, antioxidant, and anti-inflammatory compound derived from the Cannabis sativa plan
Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1.
Casares L, García V, Garrido-Rodríguez M, Millán E, Collado JA, García-Martín A, Peñarando J, Calzado MA, de la Vega L, Muñoz E. Casares L, et al. Redox Biol. 2020 Jan;28:101321. doi: 10.1016/j.redox.2019.101321. Epub 2019 Sep 5. Redox Biol. 2020. PMID: 31518892 Free PMC article.
Cannabidiol (CBD) is a major non-psychotropic phytocannabinoid that attracted a great attention for its therapeutic potential against different pathologies including skin diseases. ...In vivo studies showed that topical CBD increased the levels of HMOX1 and o
Cannabidiol (CBD) is a major non-psychotropic phytocannabinoid that attracted a great attention for its therapeutic potential against
99 results